• Explore /
  • Poster
  • / A phase I/II clinical trial of E6 T-cell receptor gene therapy for human papillomavirus (HPV)-associated epithelial cancers.

A phase I/II clinical trial of E6 T-cell receptor gene therapy for human papillomavirus (HPV)-associated epithelial cancers.

Abstract Poster

Authors

null

Christian S. Hinrichs

National Institutes of Health, National Cancer Institute, Bethesda, MD

Christian S. Hinrichs , Stacey L. Doran , Sanja Stevanovic , Sabina Adhikary , Michelle Mojadidi , Mei Li Kwong , William C Faquin , Steven Feldman , Robert Somerville , Richard Mark Sherry , James C. Yang , Steven A. Rosenberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research,Immunotherapy

Sub Track

Cellular Immunotherapy

Clinical Trial Registration Number

NCT02280811

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3009)

DOI

10.1200/JCO.2017.35.15_suppl.3009

Abstract #

3009

Poster Bd #

104

Abstract Disclosures

Similar Posters

First Author: Rosa Nadal

First Author: Stacey L. Doran

First Author: Marcelo Vailati Negrao

First Author: Michael Thomas Schweizer